Genome BC has invested $1 million in Acuva Technologies, a company based in British Columbia that provides advanced UV-LED water purification solutions.
“Our province still has communities where safe drinking water is not consistently available,” said Tony Brooks, chief financial officer and vice president of entrepreneurship and commercialization at Genome BC. “Genome BC not only seeks to better the lives of British Columbians through this investment, but also to support global efforts for the millions of people around the world who still struggle on a daily basis for access to clean water.”
The World Health Organization (2017) reported that 3.4 million people, mostly children, die from water-related diseases each year. Access to safe drinking water contributes to improved health and reduced risk of waterborne diseases. Acuva’s compact, energy efficient UV-LED water treatment technology offers a solution to address this global issue.
Acuva’s proprietary IntenseBeam™ technology, developed in partnership with the University of British Columbia (UBC), combines the proven performance of UV disinfection with the energy efficiency of LEDs. This purifies drinking water with microbial disinfection rates up to 99.9999 per cent to protect health and safety without adding any chemicals into the water.
“Our UV-LED water disinfection technology enables clean drinking water globally and protects health to improve lives, all while reducing the need for single-use plastic drinking water bottles,” said Manoj Singh, president and chief executive officer of Acuva Technologies. “This funding from Genome BC’s I2 Program will help Acuva’s rapid growth and achieve our vision of creating a positive global impact while addressing the need for safe drinking water.”
Header image credit: Acuva Technologies.
